{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:09:21Z","timestamp":1790543361757,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T00:00:00Z","timestamp":1594512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"French Agence Nationale de la Recherche","award":["ANR-13-BSV3-0018"],"award-info":[{"award-number":["ANR-13-BSV3-0018"]}]},{"name":"French Agence Nationale de la Recherche","award":["ANR-13-CE35-0003"],"award-info":[{"award-number":["ANR-13-CE35-0003"]}]},{"name":"Graduate Fellowship Program"},{"name":"University Paul Sabatier of Toulouse"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Quiescence is an unconventional mechanism of Plasmodium survival, mediating artemisinin resistance. This phenomenon increases the risk of clinical failures following artemisinin-based combination therapies (ACTs) by slowing parasite clearance and allowing the selection of parasites resistant to partner drugs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To thwart this multiresistance, the quiescent state of artemisinin-resistant parasites must be taken into consideration from the very early stages of the drug discovery process.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We designed a novel phenotypic assay we have named the quiescent-stage survival assay (QSA) to assess the antiplasmodial activity of drugs on quiescent parasites. This assay was first validated on quiescent forms from different artemisinin-resistant parasite lines (laboratory strain and field isolates), using two reference drugs with different mechanisms of action: chloroquine and atovaquone. Furthermore, the efficacies of different partner drugs of artemisinins used in ACTs were investigated against both laboratory strains and field isolates from Cambodia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our results highlight that because of the mechanism of quiescence and the respective pharmacological targets of drugs, drug efficacies on artemisinin-resistant parasites may be different between quiescent parasites and their proliferating forms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These data confirm the high relevance of adding the chemosensitivity evaluation of quiescent parasites by the specific in vitro QSA to the antiplasmodial drug development process in the current worrisome context of artemisinin resistance.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaa250","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T11:06:37Z","timestamp":1590404797000},"page":"2826-2834","source":"Crossref","is-referenced-by-count":34,"title":["Identification of compounds active against quiescent artemisinin-resistant Plasmodium falciparum parasites via the quiescent-stage survival assay (QSA)"],"prefix":"10.1093","volume":"75","author":[{"given":"Thibaud","family":"Reyser","sequence":"first","affiliation":[{"name":"LCC-CNRS, Laboratoire de Chimie de Coordination, Universit\u00e9 de Toulouse, CNRS, Toulouse, France"},{"name":"Institut de Pharmacologie et de Biologie Structurale, IPBS, Universit\u00e9 de Toulouse, CNRS, UPS, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Paloque","sequence":"additional","affiliation":[{"name":"LCC-CNRS, Laboratoire de Chimie de Coordination, Universit\u00e9 de Toulouse, CNRS, Toulouse, France"},{"name":"Institut de Pharmacologie et de Biologie Structurale, IPBS, Universit\u00e9 de Toulouse, CNRS, UPS, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Ouji","sequence":"additional","affiliation":[{"name":"LCC-CNRS, Laboratoire de Chimie de Coordination, Universit\u00e9 de Toulouse, CNRS, Toulouse, France"},{"name":"Institut de Pharmacologie et de Biologie Structurale, IPBS, Universit\u00e9 de Toulouse, CNRS, UPS, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Nguyen","sequence":"additional","affiliation":[{"name":"LCC-CNRS, Laboratoire de Chimie de Coordination, Universit\u00e9 de Toulouse, CNRS, Toulouse, France"},{"name":"Institut de Pharmacologie et de Biologie Structurale, IPBS, Universit\u00e9 de Toulouse, CNRS, UPS, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandie","family":"M\u00e9nard","sequence":"additional","affiliation":[{"name":"UMR152 UPS-IRD, Universit\u00e9 de Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Witkowski","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Augereau","sequence":"additional","affiliation":[{"name":"LCC-CNRS, Laboratoire de Chimie de Coordination, Universit\u00e9 de Toulouse, CNRS, Toulouse, France"},{"name":"Institut de Pharmacologie et de Biologie Structurale, IPBS, Universit\u00e9 de Toulouse, CNRS, UPS, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9468-4823","authenticated-orcid":false,"given":"Fran\u00e7oise","family":"Benoit-Vical","sequence":"additional","affiliation":[{"name":"LCC-CNRS, Laboratoire de Chimie de Coordination, Universit\u00e9 de Toulouse, CNRS, Toulouse, France"},{"name":"Institut de Pharmacologie et de Biologie Structurale, IPBS, Universit\u00e9 de Toulouse, CNRS, UPS, France"},{"name":"INSERM, Institut National de la Sant\u00e9 et de la Recherche Scientifique, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,12]]},"reference":[{"key":"2020101416052209400_dkaa250-B1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1098\/rstb.1999.0426","article-title":"Antimalarial drug resistance and combination chemotherapy","volume":"354","author":"White","year":"1999","journal-title":"Philos Trans R Soc Lond B"},{"key":"2020101416052209400_dkaa250-B2","year":"2019"},{"key":"2020101416052209400_dkaa250-B3","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in Western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N Engl J Med"},{"key":"2020101416052209400_dkaa250-B4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"2020101416052209400_dkaa250-B5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"2020101416052209400_dkaa250-B6","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A worldwide map of Plasmodium falciparum K13-propeller polymorphisms","volume":"374","author":"M\u00e9nard","year":"2016","journal-title":"N Engl J Med"},{"key":"2020101416052209400_dkaa250-B7","year":"2017"},{"key":"2020101416052209400_dkaa250-B8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"2020101416052209400_dkaa250-B9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1126\/science.aax4735","article-title":"A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites","volume":"367","author":"Birnbaum","year":"2020","journal-title":"Science"},{"key":"2020101416052209400_dkaa250-B10","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.01636-09","article-title":"Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism","volume":"54","author":"Witkowski","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101416052209400_dkaa250-B11","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1128\/AAC.02647-14","article-title":"Fatty acid synthesis and pyruvate metabolism pathways remain active in dihydroartemisinin-induced dormant ring stages of Plasmodium falciparum","volume":"58","author":"Chen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101416052209400_dkaa250-B12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12936-016-1206-9","article-title":"Plasmodium falciparum: multifaceted resistance to artemisinins","volume":"15","author":"Paloque","year":"2016","journal-title":"Malar J"},{"key":"2020101416052209400_dkaa250-B13","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/AAC.01868-12","article-title":"Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia","volume":"57","author":"Witkowski","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101416052209400_dkaa250-B14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1475-2875-12-263","article-title":"Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity","volume":"12","author":"Na-Bangchang","year":"2013","journal-title":"Malar J"},{"key":"2020101416052209400_dkaa250-B15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMc1403007","article-title":"Dihydroartemisinin-piperaquine failure in Cambodia","volume":"371","author":"Saunders","year":"2014","journal-title":"N Engl J Med"},{"key":"2020101416052209400_dkaa250-B16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","article-title":"Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study","volume":"15","author":"Spring","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2020101416052209400_dkaa250-B17","first-page":"409","article-title":"Artemisinin-resistant Plasmodium falciparum malaria","volume":"4","author":"Dondorp","year":"2016","journal-title":"Microbiol Spectr"},{"key":"2020101416052209400_dkaa250-B18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study","volume":"16","author":"Amaratunga","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2020101416052209400_dkaa250-B19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","article-title":"Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study","volume":"18","author":"Amato","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2020101416052209400_dkaa250-B20","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3201\/eid2110.150682","article-title":"Induction of multidrug tolerance in Plasmodium falciparum by extended artemisinin pressure","volume":"21","author":"M\u00e9nard","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2020101416052209400_dkaa250-B21","doi-asserted-by":"crossref","first-page":"285.e1","DOI":"10.1016\/j.cmi.2015.10.027","article-title":"Natural selection of K13 mutants of Plasmodium falciparum in response to artemisinin combination therapies in Thailand","volume":"22","author":"Putaporntip","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2020101416052209400_dkaa250-B22","year":"2014"},{"key":"2020101416052209400_dkaa250-B23","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1128\/AAC.00967-06","article-title":"Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes","volume":"51","author":"Benoit-Vical","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101416052209400_dkaa250-B24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/HP.S92198","article-title":"Frequently asked questions in hypoxia research","volume":"3","author":"Wenger","year":"2015","journal-title":"Hypoxia (Auckl.)"},{"key":"2020101416052209400_dkaa250-B25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.4269\/ajtmh.17-0798","article-title":"Multiple phenotypic and genotypic artemisinin sensitivity evaluation of Malian Plasmodium falciparum isolates","volume":"98","author":"Niar\u00e9","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2020101416052209400_dkaa250-B26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","article-title":"Artemisinin-based combination treatment of falciparum malaria","volume":"77","author":"Nosten","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"2020101416052209400_dkaa250-B27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J Parasitol"},{"key":"2020101416052209400_dkaa250-B28","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101416052209400_dkaa250-B29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","article-title":"Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies","volume":"13","author":"Witkowski","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2020101416052209400_dkaa250-B30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12916-015-0539-5","article-title":"Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations","volume":"13","author":"Duru","year":"2015","journal-title":"BMC Med"},{"key":"2020101416052209400_dkaa250-B31","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.lfs.2003.10.003","article-title":"Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs","volume":"74","author":"Fitch","year":"2004","journal-title":"Life Sci"},{"key":"2020101416052209400_dkaa250-B32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chembiol.2019.11.009","article-title":"Combining stage specificity and metabolomic profiling to advance antimalarial drug discovery","volume":"27","author":"Murithi","year":"2020","journal-title":"Cell Chem Biol"},{"key":"2020101416052209400_dkaa250-B33","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.4155\/fmc.13.121","article-title":"Targeting the mitochondrial electron transport chain of Plasmodium falciparum: new strategies towards the development of improved antimalarials for the elimination era","volume":"5","author":"Nixon","year":"2013","journal-title":"Future Med Chem"},{"key":"2020101416052209400_dkaa250-B34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.parint.2014.09.011","article-title":"Direct evidence for the atovaquone action on the Plasmodium cytochrome bc1 complex","volume":"64","author":"Siregar","year":"2015","journal-title":"Parasitol Int"},{"key":"2020101416052209400_dkaa250-B35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/infdis\/jiv048","article-title":"Mitochondrial membrane potential in a small subset of artemisinin-induced dormant Plasmodium falciparum parasites in vitro","volume":"212","author":"Peatey","year":"2015","journal-title":"J Infect Dis"},{"key":"2020101416052209400_dkaa250-B36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/mol.54.1.170","article-title":"Access to hematin: the basis of chloroquine resistance","volume":"54","author":"Bray","year":"1998","journal-title":"Mol Pharmacol"},{"key":"2020101416052209400_dkaa250-B37","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0006-2952(98)00184-1","article-title":"Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action","volume":"56","author":"Ginsburg","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"2020101416052209400_dkaa250-B38","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1128\/AAC.01881-12","article-title":"Defining the timing of action of antimalarial drugs against Plasmodium falciparum","volume":"57","author":"Wilson","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101416052209400_dkaa250-B39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/01913123.2011.601405","article-title":"Ultrastructural and real-time microscopic changes in P. falciparum-infected red blood cells following treatment with antimalarial drugs","volume":"35","author":"Sachanonta","year":"2011","journal-title":"Ultrastruct Pathol"},{"key":"2020101416052209400_dkaa250-B40","first-page":"4","article-title":"Mode of action of artemether\/lumefantrine (COARTEM): the sole, fixed, oral ADCC and its role in combatting multidrug-resistance","volume":"32","author":"Warhurst","year":"2001","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2020101416052209400_dkaa250-B41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0006-2952(01)00878-4","article-title":"Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes","volume":"63","author":"Famin","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"2020101416052209400_dkaa250-B42","doi-asserted-by":"crossref","first-page":"31103","DOI":"10.1074\/jbc.273.47.31103","article-title":"A common mechanism for blockade of heme polymerization by antimalarial quinolines","volume":"273","author":"Sullivan","year":"1998","journal-title":"J Biol Chem"},{"key":"2020101416052209400_dkaa250-B43","doi-asserted-by":"crossref","first-page":"17031","DOI":"10.1038\/nmicrobiol.2017.31","article-title":"Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis","volume":"2","author":"Wong","year":"2017","journal-title":"Nat Microbiol"},{"key":"2020101416052209400_dkaa250-B44","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1186\/s12864-015-2040-0","article-title":"Plasmodium parasites mount an arrest response to dihydroartemisinin, as revealed by whole transcriptome shotgun sequencing (RNA-seq) and microarray study","volume":"16","author":"Shaw","year":"2015","journal-title":"BMC Genomics"},{"key":"2020101416052209400_dkaa250-B45","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10495-016-1265-y","article-title":"Mefloquine induces ROS mediated programmed cell death in malaria parasite: Plasmodium","volume":"21","author":"Gunjan","year":"2016","journal-title":"Apoptosis"},{"key":"2020101416052209400_dkaa250-B46","doi-asserted-by":"crossref","first-page":"e23867","DOI":"10.1371\/journal.pone.0023867","article-title":"Plasmodium falciparum metacaspase PfMCA-1 triggers a z-VAD-fmk inhibitable protease to promote cell death","volume":"6","author":"Meslin","year":"2011","journal-title":"PLoS One"},{"key":"2020101416052209400_dkaa250-B47","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/656476","article-title":"Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure","volume":"202","author":"Teuscher","year":"2010","journal-title":"J Infect Dis"},{"key":"2020101416052209400_dkaa250-B48","doi-asserted-by":"crossref","first-page":"e02235","DOI":"10.1128\/AAC.02235-17","article-title":"Imidazolopiperazines kill both rings and dormant rings in wild-type and K13 artemisinin-resistant Plasmodium falciparum in vitro","volume":"62","author":"Dembele","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101416052209400_dkaa250-B49","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiz534","article-title":"A novel antiparasitic compound kills ring-stage Plasmodium falciparum and retains activity against artemisinin-resistant parasites","volume":"221","author":"Clements","year":"2020","journal-title":"J Infect Dis"},{"key":"2020101416052209400_dkaa250-B50","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/febs.14127","article-title":"Combating multidrug-resistant Plasmodium falciparum malaria","volume":"284","author":"Thu","year":"2017","journal-title":"FEBS J"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/10\/2826\/33885264\/dkaa250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/10\/2826\/33885264\/dkaa250.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T20:07:07Z","timestamp":1602706027000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/75\/10\/2826\/5870417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,12]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,7,12]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa250","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,7,12]]}}}